期刊文献+

Mallory-Denk Bodies in chronic hepatitis 被引量:7

Mallory-Denk Bodies in chronic hepatitis
下载PDF
导出
摘要 Mallory-Denk Bodies(MDB) are important as investigators,suggesting MDB as an indicator of the histologic severity of chronic hepatitis,causes of which include hepatitis C,primary biliary cirrhosis(PBC),and nonalcoholic fatty liver disease(NAFLD).Matteoni et al scored MDB in patients with NAFLD as none,rare and many,and reported that MDB plays a prominent role in this classification scheme in an earlier classification system.In this study,we evaluated 258 patients with chronic hepatitis due to metabolic,autoimmune and viral etiologies.Liver biopsy samples were evaluated with hematoxylin and eosin,periodic acid-Schiff-diastase,Gordon and Sweet's reticulin,Masson's trichrome,and iron stains.Both staging and grading were performed.Additionally,MDB were evaluated and discussed for each disease.We examined patients with nonalcoholic steatohepatitis(NASH;50 patients),alcoholic hepatitis(10 patients),PBC(50 patients),Wilson disease(WD;20 patients),hepatitis B(50 patients),hepatitis C(50 pati-ents) and hepatocellular carcinoma(HCC;30 patients).Frequency of MDB was as follows;NASH:10 patients with mild in 60% and moderate in 40% and observed in every stage of the disease and frequently seen in zone 3.PBC:11 patients with mild in 10%,moderate in 70%,and cirrhosis in 20%,and frequently seen in zone 1.WD:16 patients with moderate and severe in 60% and cirrhosis in 40% and frequently seen in zone 1.Hep B:3 patients with mild in 66% and severe in 34%.Hep C:7 patients with mild in 40% and moderate in 60% and observed in every stage.HCC:3 patients with hep B in 2 patients.We found that there is no relationship between MDB and any form of chronic hepatitis regarding histologic severity such as alcoholic steatohepatitis and NAFLD and variable zone distribution by etiology. Mallory-Denk Bodies(MDB) are important as investigators,suggesting MDB as an indicator of the histologic severity of chronic hepatitis,causes of which include hepatitis C,primary biliary cirrhosis(PBC),and nonalcoholic fatty liver disease(NAFLD).Matteoni et al scored MDB in patients with NAFLD as none,rare and many,and reported that MDB plays a prominent role in this classification scheme in an earlier classification system.In this study,we evaluated 258 patients with chronic hepatitis due to metabolic,autoimmune and viral etiologies.Liver biopsy samples were evaluated with hematoxylin and eosin,periodic acid-Schiff-diastase,Gordon and Sweet's reticulin,Masson's trichrome,and iron stains.Both staging and grading were performed.Additionally,MDB were evaluated and discussed for each disease.We examined patients with nonalcoholic steatohepatitis(NASH;50 patients),alcoholic hepatitis(10 patients),PBC(50 patients),Wilson disease(WD;20 patients),hepatitis B(50 patients),hepatitis C(50 pati-ents) and hepatocellular carcinoma(HCC;30 patients).Frequency of MDB was as follows;NASH:10 patients with mild in 60% and moderate in 40% and observed in every stage of the disease and frequently seen in zone 3.PBC:11 patients with mild in 10%,moderate in 70%,and cirrhosis in 20%,and frequently seen in zone 1.WD:16 patients with moderate and severe in 60% and cirrhosis in 40% and frequently seen in zone 1.Hep B:3 patients with mild in 66% and severe in 34%.Hep C:7 patients with mild in 40% and moderate in 60% and observed in every stage.HCC:3 patients with hep B in 2 patients.We found that there is no relationship between MDB and any form of chronic hepatitis regarding histologic severity such as alcoholic steatohepatitis and NAFLD and variable zone distribution by etiology.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第17期2172-2177,共6页 世界胃肠病学杂志(英文版)
关键词 Non-alcoholic fatty liver disease MalloryDenk Bodies Hepatitis B and C Hepatocellular carcinoma Primary biliary cirrhosis Wilson disease 非酒精的脂肪肝疾病; Mallory-Denk 身体;肝炎 B 和 C; Hepatocellular 癌;主要胆汁的肝硬化;威尔森疾病
  • 相关文献

参考文献24

  • 1Strnad P, Zatloukal K, Stumptner C, Kulaksiz H, Denk H. Mallory-Denk-bodies: lessons from keratin-containing hepat- ic inclusion bodies. Biochim Biophys Acta 2008; 1782:764-774.
  • 2Caldwell S, Ikura Y, Dias D, Isomoto K, Yabu A, Moskaluk C, Pramoonjago P, Simmons W, Scruggs H, Rosenbaum N, Wilkinson T, Toms P, Argo CK, A1-Osaimi AM, Redick JA. Hepatocellular ballooning in NASH. J Hepatol 2010; 53: 719-723.
  • 3Strnad P, Tao GZ, So P, Lau K, Schilling J, Wei Y, Liao J, Om- ary MB. "Toxic memory" via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction. Hepatology 2008; 48:931-942.
  • 4Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, Cadrin M, Omary MB. From Mallory to Mallory- Denk bodies: what, how and why? Exp Cell Res 2007; 313: 2033-2049.
  • 5Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
  • 6Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321.
  • 7Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto un- named disease. Mayo Clin Proc 1980; 55:434-438.
  • 8Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987; 82:650-654.
  • 9Nagore N, Scheuer PJ. The pathology of diabetic hepatitis. J Patho11988; 156:155-160.
  • 10Diehl AM, Goodman Z, Ishak KG. AlcohoUike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95:1056-1062.

同被引文献27

  • 1Yoshihisa Takahashi,Toshio Fukusato.Pediatric nonalcoholic fatty liver disease:Overview with emphasis on histology[J].World Journal of Gastroenterology,2010,16(42):5280-5285. 被引量:4
  • 2Metin Basaranoglu,Gkcen Basaranoglu,Hakan Sentürk.From fatty liver to fibrosis:A tale of “second hit”[J].World Journal of Gastroenterology,2013,19(8):1158-1165. 被引量:30
  • 3DominiquePessayre.Role of mitochondria in non‐alcoholic fatty liver disease[J]. Journal of Gastroenterology and Hepatology . 2007
  • 4Anja Thomas,Matthias S. Klein,Axel P. Stevens,Yvonne Reinders,Claus Hellerbrand,Katja Dettmer,Wolfram Gronwald,Peter J. Oefner,J?rg Reinders.Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet[J].Journal of Proteomics.2013
  • 5Joanna Maria Lotowska,Maria Elzbieta Sobaniec-Lotowska,Dariusz Marek Lebensztejn.The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis – ultrastructural findings. The first report in pediatric patients[J].Scandinavian Journal of Gastroenterology.2013(3)
  • 6Anabela P. Rolo,Jo?o S. Teodoro,Carlos M. Palmeira.Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis[J].Free Radical Biology and Medicine.2011(1)
  • 7Sweta Tandra,Matthew M. Yeh,Elizabeth M. Brunt,Raj Vuppalanchi,Oscar W. Cummings,Aynur ünalp-Arida,Laura A. Wilson,Naga Chalasani.Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease[J].Journal of Hepatology.2011(3)
  • 8D.G. Tiniakos.Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients[J].Gastroenterologie Clinique et Biologique.2009(10)
  • 9B Fromenty,MA Robin,A Igoudjil,A Mansouri,D Pessayre.The ins and outs of mitochondrial dysfunction in NASH[J].Diabetes and Metabolism.2004(2)
  • 10Maria E Sobaniec-Lotowska,Dariusz M Lebensztejn.Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease[J].The American Journal of Gastroenterology.2003(7)

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部